Collegium Pharmaceutical (COLL) Enterprise Value (2014 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Enterprise Value of -$288.5 million for Q1 2026, down 45.87% year-over-year from -$533.0 million in Q1 2025, and down 14.89% quarter-over-quarter from -$251.1 million in Q4 2025.
Collegium Pharmaceutical (COLL) Enterprise Value (2014 - 2026) Analysis & Trends
Collegium Pharmaceutical's Enterprise Value history runs 13 years deep, the most recent figure standing at -$288.5 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 45.87% year-over-year to -$288.5 million; the TTM figure through Mar 2026 stood at -$288.5 million (down 45.87% YoY), while the FY2025 annual figure was -$251.1 million, down 54.27% from the prior year.
- Enterprise Value for Q1 2026 stood at -$288.5 million, down from -$251.1 million in the prior quarter.
- The five-year high for Enterprise Value was -$106.7 million in Q1 2022, with the low at -$325.5 million in Q2 2023.
- The 5-year median for Enterprise Value is -$251.1 million (2025), against an average of -$222.4 million.
- The sharpest annual moves came in 2023 and 2024: Enterprise Value plunged 165.21% in 2023, then surged 60.61% in 2024.
- Collegium Pharmaceutical's Enterprise Value stood at -$173.7 million in 2022, then plunged by 78.8% to -$310.5 million in 2023, then soared by 47.59% to -$162.8 million in 2024, then sank by 54.27% to -$251.1 million in 2025, then fell by 14.89% to -$288.5 million in 2026.
- Business Quant data shows COLL's Enterprise Value at -$288.5 million in Q1 2026, -$251.1 million in Q4 2025, and -$285.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | -164.00 Mn |
| 10 | Collegium Pharmaceutical | 889.49 Mn | 740.17 Mn | 110.29 Mn | -149.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -149.32 Mn |
| Mar 31, 2026 | -288.50 Mn |
| Dec 31, 2025 | -251.10 Mn |
| Sep 30, 2025 | -285.86 Mn |
| Jun 30, 2025 | -137.20 Mn |
| Mar 31, 2025 | -197.77 Mn |
| Dec 31, 2024 | -162.76 Mn |
| Sep 30, 2024 | -119.96 Mn |
| Jun 30, 2024 | -271.63 Mn |
| Mar 31, 2024 | -318.05 Mn |
| Dec 31, 2023 | -310.55 Mn |
| Sep 30, 2023 | -304.57 Mn |
| Jun 30, 2023 | -325.47 Mn |
| Mar 31, 2023 | -269.48 Mn |
| Dec 31, 2022 | -173.69 Mn |
| Sep 30, 2022 | -134.13 Mn |
| Jun 30, 2022 | -122.72 Mn |
| Mar 31, 2022 | -106.70 Mn |
| Dec 31, 2021 | -186.43 Mn |
| Sep 30, 2021 | -193.24 Mn |